The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense ...

UCB’s continued commitment to leading research aimed at improving treatment outcomes for people living with neurological conditions.Data include the use of FINTEPLA®▼ (fenfluramine)1 in Dravet ...

Dr Ray O’Connor takes a look at the latest clinical articles on the subject of epilepsy, a common neurological disease that affects one to two per cent of the general population ...

Jazz Pharmaceuticals plc is a Buy with its robust portfolio, potential FDA approvals, and innovative oncology treatments.

Bexicaserin is being developed to treat a group of disorders known as developmental and epileptic encephalopathies (DEEs), including Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis ...

While Harmony Biosciences HRMY may not be a typical cannabis stock involved in cultivation, processing, or sales of marijuana ...

NICE estimates that there are around 1,400 people who will now be eligible for treatment with Fintepla, which was previously backed by NICE for Dravet syndrome, another severe epilepsy disorder ...

The global Oligonucleotide Synthesis Market is valued at USD 7.78 Billion in 2024 and is projected to reach a value of USD 21 ...

The neuropeptide galanin modulates whole-brain activity and stress responses in zebrafish, revealing a complex, receptor-dependent role in seizure regulation with implications for epilepsy, and ...

Feb. 5, 2025 — Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population.

Dead butt syndrome occurs when the gluteus medius stops firing due to unuse or sitting all day. Here are 5 exercises to help activate your glutes right now.

Apr. 8, 2025 — In the first comprehensive, cell-by-cell analysis of brain tissue from individuals with Tourette syndrome, researchers have pinpointed exactly which cells are perturbed and how ...